Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-02-06 am EST			5-day change	1st Jan Change
295.50 ^DKK	+5.29%		-20.04%	-9.15%

06:39pm	FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs -- Update	DJ
06:30pm	US signals crackdown on compounded weight-loss drugs; Hims shares tumble	RE

European Stocks Close Mixed in Wednesday Trading; Euro Area Inflation Declines in December

Published on 01/07/2026 at 12:18 pm EST

MT Newswires

Latest news about Novo Nordisk A/S

06:39pm	FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs -- Update	DJ
06:30pm	US signals crackdown on compounded weight-loss drugs; Hims shares tumble	RE
Feb. 06	FDA to restrict GLP-1 ingredients used in non-approved compounded drugs	RE
Feb. 06	Sector Update: Health Care Stocks Rise Late Afternoon	MT
Feb. 06	Sector Update: Health Care Stocks Rise in Afternoon Trading	MT
Feb. 06	Sector Update: Health Care	MT
Feb. 06	Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market	RE
Feb. 06	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; Little Changed for the Week	MT
Feb. 06	US FDA Warns of 'Swift Action' Against Copycat Drugs	MT
Feb. 06	Alert on Novo Nordisk initiating Wegovy commercial withdrawn	RE
Feb. 06	Sector Update: Health Care Stocks Advance Premarket Friday	MT
Feb. 06	Sector Update: Health Care	MT
Feb. 06	Top Premarket Decliners	MT
Feb. 06	Svenska Handelsbanken Upgrades Novo Nordisk to Buy, Boosts PT	MT
Feb. 06	US FDA Warns of 'Swift Action' Against Copycat Drugs	MT
Feb. 06	NOVO NORDISK : UBS is Neutral	ZD
Feb. 06	US President Launches TrumpRx.gov to Offer Branded Drugs at Discounted Prices	MT
Feb. 06	European Midday Briefing : Shares Mixed as Tech Jitters Weigh on Sentiment	DJ
Feb. 06	Novo Nordisk shares rebound as FDA targets illegal drug copies	RE
Feb. 06	Europe's STOXX 600 rebounds in broad based gains; Stellantis plunge drags auto stocks	RE
Feb. 06	FDA to Take Action Against Producers of Copycat Drugs	FW
Feb. 06	Handelsbanken Upgrades Novo Nordisk to Buy - New Sector Favorite	FW
Feb. 06	Landesbank Baden-Württemberg Lowers Price Target for Novo Nordisk to 330 Danish Kroner (from 350), Reiterates Hold - BN	FW
Feb. 06	NOVO NORDISK : JP Morgan reiterates its Buy rating	ZD
Feb. 06	Hims & Hers triggers a price war with a low-cost GLP-1 pill, putting Novo and Lilly under pressure

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.7%); - rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).

Employees

69,150

Sector

Pharmaceuticals

Calendar

Mar. 26 - Annual General Meeting

More about the company